• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

DF/HCC News

    CURE Program offers first foothold for science careers

    By Robert Levy

    The poise and self-assurance of the presenters at a research symposium at Dana-Farber made it easy to forget they are students in high school and college

    DF/HCC members awarded grants amid tight funding environment

    The NIH continues to recognize DF/HCC as a leader in cancer research by awarding funding to a number of our research initiatives

    Pathology Specimen Locator Core

    The mission of the Pathology Specimen Locator Core is to facilitate Cancer Center member access to tissue

    Tissue Microarray and Imaging Core

    The Tissue Microarray and Imaging (TMI) Core is dedicated to the construction and evaluation of high quality TMAs for cancer research

    Seventeen new members join DF/HCC

    Seventeen individuals have recently joined DF/HCC

    Testing PI3K Inhibitor BKM120 in Recurrent Glioblastoma

    Glioblastoma multiforme (GBM), or grade 4 glioma, is an aggressive brain tumor that is resistant to chemotherapy and radiation, and is almost always fatal

    The Bridge Project: Melanoma Workshop
Displaying results 43 to 49 out of 216